Document:

EX-10.3

 Exhibit 10.3 

AMENDED AND RESTATED MANAGEMENT AGREEMENT 

This AMENDED AND RESTATED MANAGEMENT AGREEMENT (this “Agreement”) is entered into as of December 5, 2012 by and among
inVentiv Group Holdings, Inc. (formerly Papillon Holdings, Inc.), a Delaware corporation (“Group Holdings”), inVentiv Midco Holdings, Inc., a Delaware corporation (“Midco Holdings”), inVentiv Holdings, Inc., a
Delaware corporation (“Holdings”), inVentiv Health, Inc., a Delaware corporation (the “Company”, and together with Group Holdings, Midco Holdings, and Holdings, the “Companies”), and Liberty Lane IH
LLC, a Delaware limited liability company (the “Sponsor”). 
 RECITALS 

WHEREAS, the Companies were formed for the purpose of engaging in a transaction in which inVentiv Acquisition, Inc. (formerly
Papillon Acquisition Inc.), a Delaware corporation (“MergerCo”) was merged with and into the Company with the Company being the surviving entity of such merger (the “Merger”) pursuant to an Agreement and Plan of
Merger by and among Group Holdings, MergerCo and the Company (the “Merger Agreement”); 
 WHEREAS, to enable
MergerCo to engage in the Merger and related transactions, Sponsor provided advice, analysis and assistance with due diligence and other investigatory matters related to the Company, its subsidiaries and the industries in which they operate and
other advisory services (the “Financial Advisory Services”); 
 WHEREAS, in connection with the Merger,
Sponsor entered into a Management Agreement with the Companies dated as of August 4, 2010 (the “Original Agreement”) providing for payment in respect of the Financial Advisory Services and to provide for the provision of
management, consulting and financial and other advisory services to the Companies following the Merger; 
 WHEREAS, Sponsor,
through certain of its executives and senior staff (collectively, the “Executives”), has been providing to the Companies management, consulting, financial, and other advisory services; 

WHEREAS, Indemnitees (as hereinafter defined) may have certain rights to indemnification, advancement of expenses and/or
insurance provided by Sponsor (or its affiliates other than the Companies), which the Companies and Sponsor intend to be secondary to the primary obligation of the Companies to indemnify Indemnitees as provided herein, with the Companies’
acknowledgement of and agreement to the foregoing being a material condition to Indemnitees’ willingness to provide services to the Companies; 

WHEREAS, the Companies desire to continue to retain Sponsor to provide certain management, consulting and financial and other
advisory services to the Companies, and Sponsor is willing to continue to provide such services on the terms set forth below; and 

WHEREAS, the Companies and Sponsor desire to amend and restate the Original Agreement in the form of this Agreement to
recognize the appointment of Paul M. Meister as Chief Executive Officer of the Companies in January of 2011. 

 AGREEMENT 

Now, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto, intending to be legally bound,
hereby agree as follows: 
 1. Services. Sponsor hereby acknowledges that Paul M. Meister has been serving as a director (Chairman)
of the Companies and as the Companies’ Chief Executive Officer, and it hereby waives any rights to exclusivity that it may have with respect to the services of Paul M. Meister to the extent necessary to enable Paul M. Meister to continue during
this Agreement’s Term (as hereinafter defined) to provide those services to the Companies. Sponsor hereby further agrees that, during the Term (as hereinafter defined) of this Agreement specified in Section 4 hereof, it will provide the
following management, consulting, financial and other advisory services to the Companies as requested from time to time by the Board of Directors or Managers or analogous governing body, as applicable, of the Companies, or by the duly authorized of
the Companies, and agreed to by Sponsor: 
 (a) advice in connection with the negotiation and consummation of agreements,
contracts, documents and instruments necessary to provide the Companies with financing on terms and conditions satisfactory to the Companies; 

(b) financial, managerial and operational advice in connection with the Companies’ day-to-day operations, including,
without limitation, advice with respect to the development and implementation of strategies for improving the operating, marketing and financial performance of the Company and its subsidiaries; 

(c) advice in connection with financing, acquisition, disposition, merger, combination and change of control transactions
involving any of the Companies (however structured); and 
 (d) such other services (which may include financial and
strategic planning and analysis, consulting services, human resources and executive recruitment services and other services) as Sponsor and the Companies may from time to time agree in writing. 

Sponsor will cause the Executives to devote such time and efforts to the performance of services contemplated hereby as Sponsor deems reasonably necessary or
appropriate; provided, however, that no minimum number of hours is or will be required to be devoted by Sponsor or any of its employees or partners on a weekly, monthly, annual or other basis. For the avoidance of doubt, the parties agree
that to the extent Paul M. Meister directs or manages other Executives of the Sponsor in connection with the provision of any of the advisory services by Sponsor as requested by the Companies, Paul M. Meister is providing such direction or
management in his capacity as a partner of Sponsor and not as an employee of the Companies. Sponsor will provide to the Compensation Committee of the Board of Directors of the Companies, for each fiscal year during the Term (as hereinafter defined)
an annual report of its services to the Companies which report will include, among other things, the names of Sponsor’s partners and employees providing services to the Companies, a summary of the services provided by each such partner and
employee and an explanation of the value provided by the Sponsor relative to the fee charged during such fiscal year. In addition, Sponsor shall promptly provide any other information regarding its services to the Companies as reasonably requested
by the Company at any time. 

  
 2 

 The Companies acknowledge that Sponsor’s services are not exclusive and that Sponsor will
render similar services to other persons and entities. Sponsor and the Companies understand that the Companies may, at times, engage one or more investment bankers or financial advisers to provide services in addition to services provided by Sponsor
under this Agreement. In providing services to the Companies, Sponsor will act as an independent contractor and it is expressly understood and agreed that this Agreement is not intended to create, and does not create, any partnership, agency, joint
venture or similar relationship and that neither Sponsor, on the one hand, nor the Companies, on the other, has the right or ability to contract for or on behalf of each other or to effect any transaction for each other’s account. 

2. Payment of Fees. After the date hereof and until the termination of this Agreement (as provided in Section 4 below), the
Companies will jointly and severally pay to Sponsor (or an affiliate of Sponsor designated by it) a non-refundable periodic retainer fee (the “Periodic Fee”) in an amount per year equal to $800,000, such fee being payable in equal
installments quarterly in advance on the first day of each fiscal quarter of the Company following the date hereof, the first such payment to be made on January 1, 2013. 

Each payment made pursuant to this Section 2 will be paid by wire transfer of immediately available federal funds to the account
specified on Schedule 1 hereto, or to such other account(s) as Sponsor may specify to the Companies in writing prior to such payment. 

Notwithstanding the foregoing, payment of all or a portion of the Periodic Fee shall be deferred to the extent necessary to avoid a breach of
any financial covenant under, or if such payment would otherwise be prohibited by, the Companies’ financing agreements and shall be promptly paid when payment thereof would no longer result in any breach of a financial covenant under, nor be
prohibited by, such financing agreements; provided that, any such deferred Periodic Fee shall accrue interest, on such portion that is deferred for the number of days that payment is deferred, at a rate equal to the 6-month treasury rate
(initially the such rate that is in effect on the first date of such deferral and adjusted on each 180th day thereafter to the rate then in effect) plus 100 basis points. 

3. Executives May Remain Employees of Sponsor. Notwithstanding anything contained in this Agreement, the Executives may remain
employees of Sponsor during the Term provided that services do not interfere with any employment obligations that the Executives or any of them may have to the Companies. Nothing contained in this Agreement shall limit Sponsor’s rights and
obligations with respect to the Executives or limit Sponsor’s right to assign additional duties to the Executives, provided that such duties do not interfere with Sponsor’s obligations set forth in Section 1 of this Agreement or with
any employment obligations that the Executives or any of them may have to the Companies. 
 4. Term. This Agreement will continue in
full force and effect until August 4, 2020 (the “Term”). Upon expiration of the Term, this Agreement shall automatically extend for successive periods of one (1) year, unless the Companies or Sponsor provide written notice, to the
Companies or Sponsor, as applicable, at least ninety (90) days prior to the end of the Term 

  
 3 

 
(or any annual extension thereof) indicating their desire not to extend the Term. Notwithstanding the foregoing, (a) the Companies may terminate this Agreement upon not less than ten
(10) days’ written notice to Sponsor, (b) Sponsor may terminate this Agreement upon not less than ten (10) days’ written notice to the Companies and (c) this Agreement shall terminate upon a Change of Control (as
defined in the Stockholders Agreement dated as of August 4, 2010, as amended, modified or supplemented, by and between Group Holdings, Midco Holdings, Holdings, MergerCo, the Company and the other parties thereto). In the case of any such
termination in accordance with this Section 4, (x) each of Sections 5, 6 and 9 (whether in respect of or relating to services rendered during or after the Term) and (y) any and all accrued and unpaid obligations of the Companies owed
under Section 2 will all survive any termination of this Agreement to the maximum extent permitted under applicable law. 
 5.
Expenses; Indemnification. 
 (a) Expenses. The Companies will jointly and severally pay on demand all expenses
incurred by Sponsor and those certain funds affiliated with or advised by Sponsor or its affiliates who are providing equity financing to Group Holdings to help effectuate the transactions contemplated by the Merger Agreement (such funds the
“Sponsor Funds” and their investments the “Equity Investments”) (or any of them) (i) in connection with this Agreement, the transactions contemplated by the Merger Agreement or any related transactions,
(ii) relating to operations of, or services provided by Sponsor to, the Companies or any of their affiliates from time to time or (iii) otherwise in any way relating to the Companies or in any way relating to, or arising out of, the Equity
Investments or the ownership or sale thereof by any Sponsor Fund. Without limiting the generality of the foregoing, the Companies jointly and severally agree to pay on demand all expenses incurred by Sponsor and the Sponsor Funds (or any of them) in
connection with, or relating to, (x) the preparation, negotiation and execution of this Agreement and any other agreement executed in connection with, or related to, this Agreement, the Merger Agreement, the financing of the transactions
contemplated by the Merger Agreement, Equity Investments or the consummation of the transactions contemplated hereby and thereby or (y) any and all amendments, modifications, restructurings and waivers, and exercises and preservations of rights
and remedies relating to any of the foregoing, and in each case will specifically include the fees and disbursements of counsel, accountants, consultants or advisors retained by Sponsor, the Sponsor Funds or their respective consultants or advisors
and any out-of-pocket expenses incurred by Sponsor in connection with the provision of services to the Companies from time to time or the attendance at any meeting of the Board of Directors or Managers (or any committee thereof) of any of the
Companies or any of their affiliates. In no event shall reimbursements provided under this Agreement be subject to liquidation or exchange in a manner that violates, and the reimbursements shall be made in a manner that complies with all,
requirements of Treasury Regulation Section 1.409A-3(i)(l)(iv). 
 (b) Indemnity and Liability. The Companies
hereby jointly and severally indemnify and agree to exonerate and hold each of Sponsor, each Sponsor Fund, and each of their respective partners, shareholders, members, affiliates, directors, officers, fiduciaries, managers, controlling persons,
employees and agents and each of the 

  
 4 

 
partners, shareholders, members, affiliates, directors, officers, fiduciaries, managers, controlling persons, employees and agents of each of the foregoing (collectively, the
“Indemnitees”), each of whom is an intended third party beneficiary of this Agreement and may specifically enforce the Companies’ obligations hereunder, free and harmless from and against any and all actions, causes of action,
suits, claims, liabilities, losses, damages and costs and expenses in connection therewith, including without limitation reasonable attorneys’ fees and expenses (collectively, the “Indemnified Liabilities”), incurred by the
Indemnitees or any of them as a result of, arising out of, or in any way relating to (i) this Agreement, the transactions contemplated by the Merger Agreement, any transaction to which the Companies are a party, the Equity Investments
(including but not limited to service as a Sponsor designated member of the Board of Directors or Managers or analogous governing body of any of the Companies or any affiliate thereof) or the ownership or sale thereof by any Sponsor Fund or any
related transactions or (ii) operations of, or services provided by Sponsor to, any of the Companies or any affiliate of any of the Companies from time to time (including but not limited to any indemnification obligations assumed or incurred by
any Indemnitee to or on behalf of any of the Companies or any of their accountants or other representatives, agents or affiliates) except for any such Indemnified Liabilities arising from such Indemnitee’s willful misconduct, and if and to the
extent that the foregoing undertaking may be unavailable or unenforceable for any reason, each of the Companies hereby agrees to make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible
under applicable law. For purposes of this Section 5(b), none of the circumstances described in the limitations contained in the immediately preceding sentence shall be deemed to apply absent a final non-appealable judgment of a court of
competent jurisdiction to such effect, in which case to the extent any such limitation is so determined to apply to any Indemnitee as to any previously advanced indemnity payments made by the Companies, then such payments shall be promptly repaid by
such Indemnitee to the Companies. The rights of any Indemnitee to indemnification hereunder will be in addition to any other rights any such person may have under any other agreement or instrument referenced above or any other agreement or
instrument to which such Indemnitee is or becomes a party or is or otherwise becomes a beneficiary or under law or regulation. The Companies hereby agree that they are the indemnitors of first resort (i.e., their obligations to any Indemnitee
under this Agreement are primary and any obligation of Sponsor (or any affiliate thereof other than the Companies) to provide advancement or indemnification for the same Indemnified Liabilities (including all interest, assessment and other charges
paid or payable in connection with or in respect of such Indemnified Liabilities) incurred by Indemnitee are secondary), and if Sponsor (or any affiliate thereof other than the Companies) pays or causes to be paid, for any reason, any amounts
otherwise indemnifiable hereunder or under any other indemnification agreement (whether pursuant to contract, bylaws or charter) with any Indemnitee, then (i) Sponsor (or such affiliate, as the case may be) shall be fully subrogated to all
rights of Indemnitee with respect to such payment and (ii) the Companies shall reimburse Sponsor (or such other affiliate) for the payments actually made. Each of the Companies hereby unconditionally and irrevocably waives,

  
 5 

 
relinquishes and releases (and covenants and agrees not to exercise, and to cause each affiliate of any of the Companies not to exercise), any claims or rights that any of the Companies may now
have or hereafter acquire against any Indemnitee (in any capacity) that arise from or relate to the existence, payment, performance or enforcement of one of the Companies’ obligations under this Agreement or under any indemnification obligation
(whether pursuant to any other contract, any organizational document or otherwise), including any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of any Indemnitee
against any Indemnitee, whether such claim, remedy or right arises in equity or under contract, statute, common law or otherwise, including any right to claim, take or receive from any Indemnitee, directly or indirectly, in cash or other property or
by set-off or in any other manner, any payment or security or other credit support on account of such claim, remedy or right. None of the Indemnitees will be liable to the Companies or any of their affiliates for any act or omission suffered or
taken by such Indemnitee that does not constitute willful misconduct. 
 6. Disclaimer and Limitation of Liability; Opportunities.

 (a) Disclaimer; Standard of Care. Sponsor makes no representations or warranties, express or implied, in respect of
the services to be provided by it hereunder. In no event will Sponsor or any of the Indemnitees be liable to any of the Companies or any of their affiliates for any act, alleged act, omission or alleged omission that does not constitute willful
misconduct of Sponsor as determined by a final, non-appealable determination of a court of competent jurisdiction. 
 (b)
Freedom to Pursue Opportunities. In recognition that Sponsor and its affiliates currently have, and will in the future have or will consider acquiring, investments in numerous companies with respect to which Sponsor or its affiliates may
serve as an advisor, a director or in some other capacity, and in recognition that Sponsor and its affiliates have myriad duties to various investors and partners, and in anticipation that the Companies and Sponsor (or one or more affiliates,
associated investment funds or portfolio companies, or clients of Sponsor) may engage in the same or similar activities or lines of business and have an interest in the same areas of corporate opportunities, and in recognition of the benefits to be
derived by the Companies hereunder and in recognition of the difficulties that may confront any advisor who desires and endeavors fully to satisfy such advisor’s duties in determining the full scope of such duties in any particular situation,
the provisions of this Section 6(b) are set forth to regulate, define and guide the conduct of certain affairs of the Companies as they may involve Sponsor. Except as Sponsor may otherwise agree in writing after the date of the Original
Agreement: 
 (i) Sponsor and its affiliates will have the right: (A) to directly or indirectly engage in any business
(including, without limitation, any business activities or lines of business that are the same as or similar to those pursued by, or competitive with, any of the Companies and their subsidiaries, (B) to directly or indirectly do business with
any client or customer of any of the Companies and 

  
 6 

 
their subsidiaries, (C) to take any other action that Sponsor believes in good faith is necessary to or appropriate to fulfill its obligations as described in the first sentence of this
Section 6(b), and (D) not to present potential transactions, matters or business opportunities to any of the Companies or any of their subsidiaries, and to pursue, directly or indirectly, any such opportunity for itself, and to direct any
such opportunity to another person. 
 (ii) Sponsor and its officers, employees, partners, members, other clients, affiliates
and other associated entities will have no duty (contractual or otherwise) to communicate or present any corporate opportunities to the Companies or any of their affiliates or to refrain from any action specified in Section 6(b)(i), and the
Companies on their own behalf and on behalf of their affiliates, hereby renounce and waive any right to require Sponsor or any of its affiliates to act in a manner inconsistent with the provisions of this Section 6(b). 

(iii) Neither Sponsor nor any officer, director, employee, partner, member, stockholder, affiliate or associated entity thereof
will be liable to the Companies or any of their affiliates for breach of any duty (contractual or otherwise) by reason of any activities or omissions of the types referred to in this Section 6(b) or of any such person’s participation
therein. 
 (c) Limitation of Liability. In no event will Sponsor or any of its affiliates be liable to the Companies
or any of their affiliates for any indirect, special, punitive, incidental or consequential damages, including, without limitation, lost profits or savings, whether or not such damages are foreseeable, or for any third party claims (whether based in
contract, tort or otherwise), relating to the services to be provided by Sponsor hereunder. 
 7. Assignment, etc. Except as provided
below, no party hereto has the right to assign this Agreement without the prior written consent of the other parties. Notwithstanding the foregoing, (a) Sponsor may assign all or part of its rights and obligations hereunder to any affiliate of
Sponsor that provides services similar to those called for by this Agreement, in which event Sponsor will be released of all of its rights and obligations hereunder and (b) the provisions hereof for the benefit of Indemnitees other than Sponsor
shall also inure to the benefit of such other Indemnitees and their successors and assigns. 
 8. Amendments and Waivers. No
amendment or waiver of any term, provision or condition of this Agreement will be effective, unless in writing and executed by each of Sponsor and the Companies. No waiver on any one occasion will extend to or effect or be construed as a waiver of
any right or remedy on any future occasion. No course of dealing of any person nor any delay or omission in exercising any right or remedy will constitute an amendment of this Agreement or a waiver of any right or remedy of any party hereto. 

  
 7 

 9. Governing Law and Arbitration. 

(a) Governing Law. This Agreement and all matters arising under or related to this Agreement will be governed by and
construed in accordance with the domestic substantive laws of the State of New York, without reference to its choice of law provisions. 

(b) Arbitration. Any disputes arising between the parties relating to, arising out of or in any way connected with the
Agreement or any term or condition hereof, or the performance by either party of its obligations hereunder, whether before or after termination of the Agreement (a “Dispute”) shall be finally resolved by binding arbitration as
herein provided. 
 (i) General. Except as otherwise provided in this Section 9, any arbitration hereunder shall
be conducted under the commercial rules of the American Arbitration Association. Each such arbitration shall be conducted in the English language by a single arbitrator appointed in accordance with such rules, provided that if either party requests
the arbitration shall be conducted by a panel of three (3) arbitrators (the “Arbitration Panel”). In the case of three (3) arbitrators, each of the Companies and Sponsor shall appoint one (1) arbitrator to the
Arbitration Panel and the third arbitrator shall be appointed by the two (2) arbitrators appointed by the Companies and Sponsor. The Arbitration Panel shall be convened upon delivery of the Notice of Arbitration (as herein defined). Any such
arbitration shall be held in Boston, Massachusetts. The Arbitration Panel shall have the authority to grant specific performance, and to allocate between the parties the costs of arbitration in such equitable manner as it shall determine. Judgment
upon the award so rendered may be entered in any court having jurisdiction or application may be made to such court for judicial acceptance of any award and an order of enforcement, as the case may be. 

(ii) Procedure. 

(A) Whenever a party (the “Claimant”) shall decide to institute arbitration proceedings, it shall give
written notice to that effect (the “Notice of Arbitration”) to the other party (the “Respondent”). The Notice of Arbitration shall set forth in detail the nature of the Dispute, the facts upon which the Claimant
relies and the issues to be arbitrated (collectively, the “Arbitration Issues”). Within fifteen (15) days of its receipt of the Notice of Arbitration, the Respondent shall send the Claimant and the Arbitration Panel a written
Response (the “Response”). The Response shall set forth in detail the facts upon which the Respondent relies. In addition, the Response shall contain all counterclaims which the Respondent may have against the Claimant which are
within the Arbitration Issues, whether or not such claims have previously been identified. If the Response sets forth a counterclaim, the Claimant may, within fifteen (15) days of the receipt of the Response, deliver to the Respondent and the
Arbitration Panel a rejoinder answering such counterclaim. 
 (B) Within fifteen (15) days after the later of
(x) the expiration of the period provided in Section 9(b)(ii)(A) above for the Claimant to deliver a 

  
 8 

 
rejoinder or (y) the completion of any discovery proceedings authorized by the Arbitration Panel: (I) the Claimant shall send to the Arbitration Panel a proposed resolution of the
Arbitration Issues and a proposed resolution of any counterclaims set forth in the Response, including without limitation the amount of monetary damages, if any, or other relief sought (the “Claimant’s Proposal”); and (II) the
Respondent shall send to the Arbitration Panel a proposed resolution of the Arbitration Issues, a proposed resolution of any counterclaims set forth in the Response and a proposed resolution of any rejoinder submitted by the Claimant, including
without limitation the amount of monetary damages, if any, or other relief sought (the “Respondent’s Proposal”). Once both the Claimant’s Proposal and the Respondent’s Proposal have been submitted, the Arbitration
Panel shall deliver to each party a copy of the other party’s proposal. 
 (C) The Arbitration Panel shall issue an
opinion with respect to any Dispute, which opinion shall explicitly accept either the Claimant’s Proposal or the Respondent’s Proposal in its entirety (the “Final Decision”). The Arbitration Panel shall not have the
authority to reach a Final Decision that provides remedies or requires payments other than those set forth in the Claimant’s Proposal or the Respondent’s Proposal. The concurrence of two (2) arbitrators shall be sufficient for the
entry of a Final Decision. The arbitrators shall issue a Final Decision within one (1) month from the later of (x) the last day for submission of proposals under Section 9(b)(ii)(B) above or (y) the date of the final hearing on
any Dispute held by the Arbitration Panel. A Final Decision shall be binding on both parties. 
 10. Entire Agreement. This Agreement
contains the entire understanding of the parties with respect to the subject matter hereof and supersedes any prior communication or agreement with respect thereto. 

11. Notice. All notices, demands, and communications required or permitted under this Agreement will be in writing and will be
effective if served upon such other party and such other party’s copied persons as specified below to the address set forth for it below (or to such other address as such party will have specified by notice to each other party) if
(i) delivered personally, (ii) sent and received by facsimile or (iii) sent by certified or registered mail or by Federal Express, UPS or any other comparably reputable overnight courier service, postage prepaid, to the appropriate
address as follows: 
 If to the Companies, or any of them, to them at: 

 

			
	c/o Thomas H. Lee Partners, L.P.
	100 Federal Street
	Boston, Massachusetts 02110
	Attention:	  	Todd M. Abbrecht
	Facsimile:	  	(617) 227-3514

  
 9 

 with a copy to: 
  

			
	Ropes & Gray LLP
	800 Boylston Street
	Prudential Tower
	Boston, Massachusetts 02199
	Attention:	  	David C. Chapin, Esq.
		  	Julie H. Jones, Esq.
	Facsimile:	  	(617) 951-7050

 If to Sponsor, to it at: 
  

			
	c/o Liberty Lane Partners, LLC
	One Liberty Lane
	Hampton, NH 03842
	Attention:	  	Paul M. Meister

 Unless otherwise specified herein, such notices or other communications will be deemed
effective, (a) on the date received, if personally delivered or sent by facsimile during normal business hours, (b) on the business day after being received if sent by facsimile other than during normal business hours, (c) one
business day after being sent by Federal Express, UPS or other comparably reputable delivery service and (d) five business days after being sent by registered or certified mail. Each of the parties hereto shall be entitled to specify a
different address by giving notice as aforesaid to each of the other parties hereto. 
 12. Severability. If in any judicial or
arbitral proceedings a court or arbitrator refuses to enforce any provision of this Agreement, then such unenforceable provision will be deemed eliminated from this Agreement for the purpose of such proceedings to the extent necessary to permit the
remaining provisions to be enforced. To the full extent, however, that the provisions of any applicable law may be waived, they are hereby waived to the end that this Agreement be deemed to be valid and binding agreement enforceable in accordance
with its terms, and in the event that any provision hereof is found to be invalid or unenforceable, such provision will be construed by limiting it so as to be valid and enforceable to the maximum extent consistent with and possible under applicable
law. 
 13. Counterparts. This Agreement may be executed in any number of counterparts and by each of the parties hereto in separate
counterparts, each of which when so executed will be deemed to be an original and all of which together will constitute one and the same agreement. 

[The remainder of this page is intentionally left blank. Signatures follow.] 

  
 10 

 IN WITNESS WHEREOF, each of the parties has caused
this Agreement to be executed on its behalf as an instrument under seal as of the date first above written by its officer or representative thereunto duly authorized. 
  

									
	THE COMPANIES:	 		 	INVENTIV GROUP HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Eric Sherbet

		 		 		 	Name:	 	Eric Sherbet
		 		 		 	Title:	 	General Counsel
			
		 		 	INVENTIV MIDCO HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Eric Sherbet

		 		 		 	Name:	 	Eric Sherbet
		 		 		 	Title:	 	General Counsel
			
		 		 	INVENTIV HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Eric Sherbet

		 		 		 	Name:	 	Eric Sherbet
		 		 		 	Title:	 	General Counsel
			
		 		 	INVENTIV HEALTH, INC.
				
		 		 	By:	 	 /s/ Eric Sherbet

		 		 		 	Name:	 	Eric Sherbet
		 		 		 	Title:	 	General Counsel
			
	SPONSOR:	 		 	LIBERTY LANE IH LLC
				
		 		 	By:	 	 /s/ Paul M. Meister

		 		 		 	Name:	 	
		 		 		 	Title:	 	

 Schedule 1 to Management Agreement 

Wire Transfer Instructions for Sponsor 
  

			
	Bank:	  	Citizens Bank
	ABA #:	  	011 500 120
		  	Liberty Lane IH LLC
		  	One Liberty Lane
	For:	  	Hampton, NH 03842
	Acct #:	  	33-11830980

			
	Type:	 	MoM Performance-Based Option
	Name:	 	Liberty Lane IH LLC
	Number of Shares of Stock subject to Option:	 	25,369
	Price Per Share:	 	$132.95
	Date of Grant:	 	November 12, 2012

 INVENTIV GROUP HOLDINGS, INC.

 2010 EQUITY INCENTIVE PLAN FOR LIBERTY
LANE 
 THIS STOCK OPTION AND ANY SECURITIES ISSUED UPON EXERCISE OF THIS STOCK OPTION ARE SUBJECT TO RESTRICTIONS ON
VOTING AND TRANSFER AND REQUIREMENTS OF SALE AND OTHER PROVISIONS AS SET FORTH IN THE STOCKHOLDERS AGREEMENT. 
 INVENTIV GROUP
HOLDINGS, INC. STRONGLY ENCOURAGES YOU TO SEEK THE ADVICE OF YOUR OWN LEGAL AND FINANCIAL ADVISORS WITH RESPECT TO YOUR STOCK OPTION AND ITS TAX CONSEQUENCES. 

NON-STATUTORY STOCK OPTION AGREEMENT 

This agreement (this “Agreement”) evidences a stock option granted by inVentiv Group Holdings, Inc. (f/k/a Papillon Holdings,
Inc.) (the “Company”) to Liberty Lane IH LLC (the “Optionee”) pursuant to and subject to the terms of the inVentiv Group Holdings, Inc. 2010 Equity Incentive Plan for Liberty Lane (the “Plan”),
which is incorporated herein by reference. 
 1. Grant of Stock Option. The Company grants to the Optionee on the date of grant set
forth above (the “Date of Grant”) an option (the “Stock Option”) to purchase, on the terms provided herein and in the Plan, the number of shares of Stock of the Company set forth above (the
“Shares”) with an exercise price per Share as set forth above, in each case subject to adjustment pursuant to Section 7 of the Plan in respect of transactions occurring after the date hereof. 

The Stock Option evidenced by this Agreement is a non-statutory option (that is, an option that is not to be treated as a stock option
described in subsection (b) of Section 422 of the Code) and is granted to the Optionee in connection with the Optionee’s Service to the Company and its qualifying subsidiaries. 

2. Meaning of Certain Terms. Except as otherwise defined herein (including, for the avoidance of doubt, in the Schedules attached
hereto, which are incorporated herein and are a part hereof), all capitalized terms used herein have the same meaning as in the Plan. The following terms have the following meanings: 

 

	 	(a)	 “Cash Proceeds” means, as of any Determination Date occurring after the Closing Date, all sale proceeds, distributions and dividends
received by the Investors after the Closing Date and on or before such Determination 

	 	
Date in respect of the Investor Shares in cash or Marketable Securities, and excludes, for the avoidance of doubt, any management, consulting, monitoring, advisory, transaction or similar fee, if
any, received by the Investors or any of their affiliates. 

  

	 	(b)	“Change of Control” means any change in the ownership of the capital stock of the Company if, immediately after giving effect thereto, (i) any Person (or group of Persons acting in concert) other
than the Investors will have the direct or indirect power to elect a majority of the members of the Board or (ii) the Investors shall own less than 25% of the Equivalent Shares. 

 

	 	(c)	“Closing Date” means August 4, 2010. 

  

	 	(d)	“Determination Date” means as to any cash received by the Investors in respect of their Investor Shares, the date such cash is actually received, or as to any Marketable Securities actually received by
the Investors in respect of their Investor Shares, the “measurement date” referred to in Schedule A attached hereto. 

  

	 	(e)	“Distributed Securities” means Investor Shares or any equity securities received by the Investors in substitution or exchange for such Investor Shares, in each case only to the extent distributed in
kind in a distribution by an Investor to its limited partners or members, as applicable. 

  

	 	(f)	“Equivalent Shares” means, at any date of determination, (i) as to any outstanding shares of Stock, such number of shares of Stock and (ii) as to any outstanding options, warrants, or
convertible securities, the maximum number of shares of Stock for which or into which such options, warrants or convertible securities may at the time be exercised, converted or exchanged (or which will become exercisable, convertible or
exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which the number of Equivalent Shares is to be determined). 

  

	 	(g)	“Investment” means the total amount of cash invested by the Investors in exchange for the Investor Shares prior to the applicable Determination Date, which as of the date hereof equals $473,548,303.53.

  

	 	(h)	“Investor Shares” means all shares of the Company’s Stock issued to the Investors prior to the applicable Determination Date, and shall include any stock, securities or other property or interests
received by the Investors in respect of such shares in connection with any stock dividend or other similar distribution, stock split or combination of shares, recapitalization, conversion, reorganization, consolidation, split-up, spin-off,
combination, repurchase, merger, exchange of stock or other transaction that affects the Company’s Stock occurring after the date of issuance. 

  
 -2- 

	 	(i)	“Investors” means Thomas H. Lee Partners, L.P. and its related investment funds that hold shares of the Company’s Stock. 

 

	 	(j)	“Marketable Securities” means (i) Distributed Securities, and (ii) any equity securities (other than Distributed Securities) received by the Investors in respect of either Stock constituting
Investor Shares or any equity securities previously received by the Investors in substitution or exchange for such Stock (but excluding, for the avoidance of doubt, Stock or any equity security issued by the Company in substitution or exchange for
such Stock), in any such case that are traded on a national securities exchange and (1) are not subject to a contractual lock up or similar agreement restricting transferability, (2) may be distributed or resold without volume limitation
or other restrictions on transfer under Rule 144 under the Securities Act of 1933, as amended (or any successor provision thereof), including without application of paragraphs (c), (e), (f) and (h) of such Rule 144, and (3) are not
subject to any other prohibitions or material restrictions on transfer under applicable securities laws (including, for example, Investors’ possession of material nonpublic information which, if used in purchasing or selling such equity
securities, would result in a violation of Rule 10b-5 promulgated under the Securities Exchange Act of 1934). 

  

	 	(k)	“Trading Day” means each business day on which the Trading Price of the Marketable Securities is reported by the principal national securities exchange on which such Marketable Securities are listed or
admitted to trade. 

  

	 	(l)	“Trading Price” means, in respect of each Trading Day, the closing price on such day of a share of Marketable Securities as reported on the principal national securities exchange on which shares of
Marketable Securities are then listed or admitted to trade. 

 3. Vesting; Method of Exercise; Treatment of the Stock
Option Upon Cessation of Service. 
  

	 	(a)	Generally. As used herein with respect to the Stock Option or any portion thereof, the term “vest” means to become exercisable and the term “vested” as applied to any portion of the Stock
Option means that such portion is then exercisable, subject in each case to the terms of the Plan. Unless earlier terminated, relinquished or expired, the Stock Option will vest in accordance with the terms of Schedule A attached hereto.

  

	 	(b)	 Exercise of the Stock Option. No portion of the Stock Option may be exercised until such portion vests. Each election to exercise any vested
portion of the Stock Option will be subject to the terms and conditions of the Plan and shall be in writing, subject to any restrictions provided under the Plan and the Stockholders Agreement and to such additional

  
 -3- 

	 	
administrative rules as the Administrator may reasonably prescribe. Each such written exercise election must be received by the Company at its principal office or by such other party as the
Administrator may reasonably prescribe and be accompanied by payment in full as provided in the Plan. The exercise price may be paid (i) by cash or check acceptable to the Administrator, (ii) at the election of the Optionee, by the
Administrator’s holding back shares otherwise deliverable upon exercise having a fair market value, as determined by the Administrator, equal to the aggregate exercise price for the portion of the Stock Option being exercised, (iii) by
such other means, if any, as may be acceptable to the Administrator, or (iv) by any combination of the foregoing permissible forms of payment. The Company will be under no obligation to deliver shares hereunder unless and until it is satisfied
that the person exercising the Stock Option has been authorized to do so by the Optionee and the exercise is in compliance with applicable securities laws and the terms of the Stockholders Agreement. The latest date on which the Stock Option or any
portion thereof may be exercised will be the 10th anniversary of the Date of Grant (the “Final Exercise Date”) and if not exercised by such date, or earlier forfeited or otherwise terminated, the Stock Option or any remaining
portion thereof will thereupon immediately terminate. 

  

	 	(c)	Treatment of the Stock Option Upon Cessation of Service. If the Optionee’s Service ceases, the Stock Option to the extent not already vested shall, to the extent eligible for continued vesting pursuant to
paragraphs 1 and 2 of Schedule A attached hereto, be eligible for such continued vesting under Schedule A attached hereto (or, if not eligible, be immediately forfeited), and any vested portion of the Stock Option that is then
outstanding will be treated as follows. The Stock Option, to the extent vested immediately prior to the cessation of the Optionee’s Service, will remain outstanding and exercisable until the earlier of (i) the date that is nine
(9) months following the termination of the Optionee’s Service, and (ii) the Final Exercise Date, and then, except to the extent previously exercised, will thereupon immediately terminate. 

4. Share Restrictions, Etc. Not later than upon the execution of this Agreement and as a condition to the effectiveness of this Stock
Option, the Optionee shall execute and deliver a counterpart signature page to, and become a party to, the Stockholders Agreement as a “Manager” thereunder. The Optionee’s rights hereunder (including with respect to shares received
upon exercise) are subject to the additional restrictions and other provisions contained in the Stockholders Agreement. 
 5. Legends,
Etc. Shares issued upon exercise of the Stock Option or otherwise delivered in satisfaction of the Stock Option will bear such legends as may be required or provided for under the terms of the Stockholders Agreement. 

6. Transfer of Stock Option. The Stock Option may not be transferred except as expressly permitted under Section 6(a)(3) of the
Plan. 

  
 -4- 

 7. Withholding. The Optionee expressly acknowledges and agrees that the Optionee’s
rights hereunder, including the right to be issued shares upon exercise, are subject to the Optionee’s promptly paying, or in respect of any later requirement of withholding being liable promptly to pay at such time as such withholdings are
due, to the Company in cash (or by such other means as may be acceptable to the Administrator in its discretion) all taxes required to be withheld, if any. No shares will be transferred pursuant to the exercise of the Stock Option unless and until
the person exercising the Stock Option has remitted to the Company an amount in cash sufficient to satisfy any federal, state, or local requirements with respect to tax withholdings then due and has committed (and by exercising the Stock Option the
Optionee shall be deemed to have committed) to pay in cash all tax withholdings required at any later time in respect of the transfer of such shares, or has made other arrangements satisfactory to the Administrator with respect to such taxes. The
Optionee also authorizes the Company and its subsidiaries to withhold such amounts from any amounts otherwise owed to the Optionee, but nothing in this sentence shall be construed as relieving the Optionee of any liability for satisfying its
obligations under the preceding provisions of this Section. 
 8. Effect on Service. Neither the grant of the Stock Option, nor the
issuance of shares upon exercise of the Stock Option, will give the Optionee any right to continued Service with the Company or any of its Affiliates, affect the right of the Company or any of its Affiliates to terminate the Management Agreement at
any time, or affect any right of such Optionee to terminate the Management Agreement at any time. 
 9. Governing Law. This Agreement
and all claims or disputes arising out of or based upon this Agreement or relating to the subject matter hereof will be governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any
choice or conflict of laws provision or rule that would cause the application of the domestic substantive laws of any other jurisdiction. 

By acceptance of the Stock Option, the Optionee agrees hereby to become a party to, and be bound by the terms of, the Stockholders Agreement
and to be subject to the terms of the Plan. For the avoidance of doubt, the provisions of this Agreement and the Plan shall apply to the Stock Option, including without limitation the vesting (if any) of the Stock Option, notwithstanding any
provision relating to the vesting or other treatment of equity-based awards of the Company or its Affiliates contained in any other agreement between the Optionee and the Company or any Affiliate. The Optionee further acknowledges and agrees that
(i) the signature to this Agreement on behalf of the Company is an electronic signature that will be treated as an original signature for all purposes hereunder and (ii) such electronic signature will be binding against the Company and
will create a legally binding agreement when this Agreement is countersigned by the Optionee. 
 [The remainder of this page intentionally
left blank] 

  
 -5- 

 Executed as of the 5th day of December, 2012. 

 

							
	Company:	 		 	INVENTIV GROUP HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Eric M. Sherbet

		 		 	Name:	 	Eric M. Sherbet
		 		 	Title:	 	General Counsel

  
 [Signature Page to
Non-Statutory MoM Performance-Based Option Agreement] 

							
	Optionee:	 		 	LIBERTY LANE IH LLC
				
		 		 	By:	 	 /s/ Paul M. Meister

		 		 	Name:	 	
		 		 	Title:	 	

  
 [Signature Page to
Non-Statutory MoM Performance-Based Option Agreement] 

 Schedule A 

Vesting Schedule 
 Unless
earlier terminated or forfeited, the Stock Option will vest, if at all, in accordance with the provisions of this Schedule A: 
 1.
The Stock Option will vest as to 100% of the Shares subject to the Stock Option upon the realization by the Investors of Cash Proceeds in respect of the Investor Shares of 5x or greater of the Investment. No realization by the Investors of Cash
Proceeds in respect of the Investor Shares that on a cumulative basis amount to less than 5x of the Investment shall result in any vesting of the Stock Option pursuant to this paragraph 1, but prior realizations shall be taken into account in
determining whether and if so to what extent any later realization by the Investors of Cash Proceeds in respect of the Investor Shares (occurring prior to the forfeiture or termination of the Stock Option) results in vesting pursuant to the
immediately preceding sentence. Vesting shall be determined on each Determination Date. Notwithstanding the foregoing, except as provided in paragraph 2 of this Schedule A, the Stock Option shall not vest on any vesting date unless the
Optionee has remained in continuous Service from the Date of Grant until such vesting date. 
 2. On the Trigger Date (defined herein), the
unvested portion of the Stock Option will remain outstanding and eligible to vest in accordance with paragraph 1 above of this Schedule A until the earlier of (1) the fifth (5th) anniversary of the Trigger Date or (2) the Final
Exercise Date. The “Trigger Date” is the first date upon which all of the following have occurred: (i) each of Todd Abbrecht, Tony DiNovi and Scott Sperling ceases to be Managing Directors of Thomas H. Lee Partners, L.P.
(“THL”); and thereafter (ii) the Optionee’s Service ceases. 
 3. For purposes of this Agreement, (A) the
value of “Marketable Securities” shall be tested on (i) the date of initial receipt of Marketable Securities by the Investors (or, in the case of equity securities received by the Investors in respect of Investor Shares that do not
constitute Marketable Securities on the initial date of receipt, the date, if any, on which such equity securities received by the Investors first constitute Marketable Securities) (ii) in the case of Distributed Securities, the date of the
distribution by the Investor to its limited partners or members, as applicable, and (iii) in respect of all Marketable Securities other than Distributed Securities, the last day of each calendar quarter beginning with the calendar quarter
within which the initial receipt of such Marketable Securities to be tested occurred (or the date, if any, on which securities to be tested first constitute Marketable Securities, as applicable) so long as such Marketable Securities constituted
Marketable Securities on at least a majority of the days during such calendar quarter, and in the case of each of clauses (A)(i), (A)(ii) and (A)(iii) above only to the extent (x) such measurement date occurs while the Stock Option remains
outstanding and eligible to vest in accordance with paragraphs 1 and 2 of this Schedule A and (y) with respect to a measurement date on which the value of the Marketable Securities is determined pursuant to clause (B)(iii) below, there
exists a Trading Price in respect of such Marketable Securities for each of the thirty (30) consecutive Trading Days immediately preceding such measurement date (each of the foregoing testing dates,

 
a “measurement date”), and (B) the value of Marketable Securities for purposes of each measurement date hereunder shall be equal to (i) in the case of Marketable Securities
received in a Change of Control and that constitute Marketable Securities on the date of receipt, the value attributed to such securities in the Change of Control, (ii) in the case of Marketable Securities that constitute Marketable Securities
as a result of their being Distributed Securities, the value attributed to such securities by the Investors for purposes of making such distribution, and (iii) in all other circumstances the average of the Trading Price of such Marketable
Securities over each of the thirty (30) consecutive Trading Days immediately preceding (and including) the applicable measurement date; provided, however, that the Administrator, after consultation with the Chief Executive Officer, shall be
entitled to make equitable adjustments to the valuation methodology described in clause (B)(iii) above in respect of a particular measurement date in the event of an extraordinary transaction occurring during the thirty (30) Trading Day period
ending on such measurement date. Notwithstanding anything else in this paragraph 3, in no event shall the Stock Option remain outstanding beyond the Final Exercise Date. 

4. In the event (i) any equity securities received by the Investors in respect of the Investor Shares are excluded from the definition of
Marketable Securities when received (and at the time of a Change of Control if such equity securities are received prior to a Change of Control) as a result of the definition of Marketable Securities, (ii) a Change of Control occurs, and
(iii) the Stock Option does not fully vest in connection with the Change of Control immediately following which the Investors will continue to hold the equity securities that do not then constitute Marketable Securities, the Administrator will
provide, in connection with such Change of Control, for such adjustments with respect to the Stock Option as the Administrator, after consultation with the Company’s Chief Executive Officer, deems fair and equitable, which adjustments shall be
limited to providing for substitute equity awards, a “cash out” payment or a combination thereof, in each case subject to vesting conditions and other restrictions that are substantially the same as (or no less favorable to the Optionee
than) those contained in the Stock Option. 
 5. All determinations regarding the amount of Cash Proceeds received by the Investors in
respect of the Investor Shares and whether (or to what extent) this Stock Option has vested as a result thereof shall be made in good faith by the Board or by a committee designated by the Board, which determination shall be final and binding. 

			
	Type:	 	MoM Performance-Based Option
	Name:	 	Liberty Lane IH LLC
	Number of Shares of Stock subject to Option:	 	54,104
	Price Per Share:	 	$132.95
	Date of Grant:	 	November 12, 2012

 INVENTIV GROUP HOLDINGS, INC.

 2010 EQUITY INCENTIVE PLAN FOR LIBERTY
LANE 
 THIS STOCK OPTION AND ANY SECURITIES ISSUED UPON EXERCISE OF THIS STOCK OPTION ARE SUBJECT TO RESTRICTIONS ON
VOTING AND TRANSFER AND REQUIREMENTS OF SALE AND OTHER PROVISIONS AS SET FORTH IN THE STOCKHOLDERS AGREEMENT. 
 INVENTIV GROUP
HOLDINGS, INC. STRONGLY ENCOURAGES YOU TO SEEK THE ADVICE OF YOUR OWN LEGAL AND FINANCIAL ADVISORS WITH RESPECT TO YOUR STOCK OPTION AND ITS TAX CONSEQUENCES. 

NON-STATUTORY STOCK OPTION AGREEMENT 

This agreement (this “Agreement”) evidences a stock option granted by inVentiv Group Holdings, Inc. (f/k/a Papillon Holdings,
Inc.) (the “Company”) to Liberty Lane IH LLC (the “Optionee”) pursuant to and subject to the terms of the inVentiv Group Holdings, Inc. 2010 Equity Incentive Plan for Liberty Lane (the “Plan”),
which is incorporated herein by reference. 
 1. Grant of Stock Option. The Company grants to the Optionee on the date of grant set
forth above (the “Date of Grant”) an option (the “Stock Option”) to purchase, on the terms provided herein and in the Plan, the number of shares of Stock of the Company set forth above (the
“Shares”) with an exercise price per Share as set forth above, in each case subject to adjustment pursuant to Section 7 of the Plan in respect of transactions occurring after the date hereof. 

The Stock Option evidenced by this Agreement is a non-statutory option (that is, an option that is not to be treated as a stock option
described in subsection (b) of Section 422 of the Code) and is granted to the Optionee in connection with the Optionee’s Service to the Company and its qualifying subsidiaries. 

2. Meaning of Certain Terms. Except as otherwise defined herein (including, for the avoidance of doubt, in the Schedules attached
hereto, which are incorporated herein and are a part hereof), all capitalized terms used herein have the same meaning as in the Plan. The following terms have the following meanings: 

 

	 	(a)	 “Cash Proceeds” means, as of any Determination Date occurring after the Closing Date, all sale proceeds, distributions and dividends
received by the Investors after the Closing Date and on or before such Determination 

	 	
Date in respect of the Investor Shares in cash or Marketable Securities, and excludes, for the avoidance of doubt, any management, consulting, monitoring, advisory, transaction or similar fee, if
any, received by the Investors or any of their affiliates. 

  

	 	(b)	“Change of Control” means any change in the ownership of the capital stock of the Company if, immediately after giving effect thereto, (i) any Person (or group of Persons acting in concert) other
than the Investors will have the direct or indirect power to elect a majority of the members of the Board or (ii) the Investors shall own less than 25% of the Equivalent Shares. 

 

	 	(c)	“Closing Date” means August 4, 2010. 

  

	 	(d)	“Determination Date” means as to any cash received by the Investors in respect of their Investor Shares, the date such cash is actually received, or as to any Marketable Securities actually received by
the Investors in respect of their Investor Shares, the “measurement date” referred to in Schedule A attached hereto. 

  

	 	(e)	“Distributed Securities” means Investor Shares or any equity securities received by the Investors in substitution or exchange for such Investor Shares, in each case only to the extent distributed in
kind in a distribution by an Investor to its limited partners or members, as applicable. 

  

	 	(f)	“Equivalent Shares” means, at any date of determination, (i) as to any outstanding shares of Stock, such number of shares of Stock and (ii) as to any outstanding options, warrants, or
convertible securities, the maximum number of shares of Stock for which or into which such options, warrants or convertible securities may at the time be exercised, converted or exchanged (or which will become exercisable, convertible or
exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which the number of Equivalent Shares is to be determined). 

  

	 	(g)	“Investment” means the total amount of cash invested by the Investors in exchange for the Investor Shares prior to the applicable Determination Date, which as of the date hereof equals $473,548,303.53.

  

	 	(h)	“Investor Shares” means all shares of the Company’s Stock issued to the Investors prior to the applicable Determination Date, and shall include any stock, securities or other property or interests
received by the Investors in respect of such shares in connection with any stock dividend or other similar distribution, stock split or combination of shares, recapitalization, conversion, reorganization, consolidation, split-up, spin-off,
combination, repurchase, merger, exchange of stock or other transaction that affects the Company’s Stock occurring after the date of issuance. 

  
 -2- 

	 	(i)	“Investors” means Thomas H. Lee Partners, L.P. and its related investment funds that hold shares of the Company’s Stock. 

 

	 	(j)	“Marketable Securities” means (i) Distributed Securities, and (ii) any equity securities (other than Distributed Securities) received by the Investors in respect of either Stock constituting
Investor Shares or any equity securities previously received by the Investors in substitution or exchange for such Stock (but excluding, for the avoidance of doubt, Stock or any equity security issued by the Company in substitution or exchange for
such Stock), in any such case that are traded on a national securities exchange and (1) are not subject to a contractual lock up or similar agreement restricting transferability, (2) may be distributed or resold without volume limitation
or other restrictions on transfer under Rule 144 under the Securities Act of 1933, as amended (or any successor provision thereof), including without application of paragraphs (c), (e), (f) and (h) of such Rule 144, and (3) are not
subject to any other prohibitions or material restrictions on transfer under applicable securities laws (including, for example, Investors’ possession of material nonpublic information which, if used in purchasing or selling such equity
securities, would result in a violation of Rule 10b-5 promulgated under the Securities Exchange Act of 1934). 

  

	 	(k)	“Trading Day” means each business day on which the Trading Price of the Marketable Securities is reported by the principal national securities exchange on which such Marketable Securities are listed or
admitted to trade. 

  

	 	(l)	“Trading Price” means, in respect of each Trading Day, the closing price on such day of a share of Marketable Securities as reported on the principal national securities exchange on which shares of
Marketable Securities are then listed or admitted to trade. 

 3. Vesting; Method of Exercise; Treatment of the Stock
Option Upon Cessation of Service. 
  

	 	(a)	Generally. As used herein with respect to the Stock Option or any portion thereof, the term “vest” means to become exercisable and the term “vested” as applied to any portion of the Stock
Option means that such portion is then exercisable, subject in each case to the terms of the Plan. Unless earlier terminated, relinquished or expired, the Stock Option will vest in accordance with the terms of Schedule A attached hereto.

  

	 	(b)	 Exercise of the Stock Option. No portion of the Stock Option may be exercised until such portion vests. Each election to exercise any vested
portion of the Stock Option will be subject to the terms and conditions of the Plan and shall be in writing, subject to any restrictions provided under the Plan and the Stockholders Agreement and to such additional

  
 -3- 

	 	
administrative rules as the Administrator may reasonably prescribe. Each such written exercise election must be received by the Company at its principal office or by such other party as the
Administrator may reasonably prescribe and be accompanied by payment in full as provided in the Plan. The exercise price may be paid (i) by cash or check acceptable to the Administrator, (ii) at the election of the Optionee, by the
Administrator’s holding back shares otherwise deliverable upon exercise having a fair market value, as determined by the Administrator, equal to the aggregate exercise price for the portion of the Stock Option being exercised, (iii) by
such other means, if any, as may be acceptable to the Administrator, or (iv) by any combination of the foregoing permissible forms of payment. The Company will be under no obligation to deliver shares hereunder unless and until it is satisfied
that the person exercising the Stock Option has been authorized to do so by the Optionee and the exercise is in compliance with applicable securities laws and the terms of the Stockholders Agreement. The latest date on which the Stock Option or any
portion thereof may be exercised will be the 10th anniversary of the Date of Grant (the “Final Exercise Date”) and if not exercised by such date, or earlier forfeited or otherwise terminated, the Stock Option or any remaining
portion thereof will thereupon immediately terminate. 

  

	 	(c)	Treatment of the Stock Option Upon Cessation of Service. If the Optionee’s Service ceases, the Stock Option to the extent not already vested shall, to the extent eligible for continued vesting pursuant to
paragraphs 1 and 2 of Schedule A attached hereto, be eligible for such continued vesting under Schedule A attached hereto (or, if not eligible, be immediately forfeited), and any vested portion of the Stock Option that is then
outstanding will be treated as follows. The Stock Option, to the extent vested immediately prior to the cessation of the Optionee’s Service, will remain outstanding and exercisable until the earlier of (i) the date that is nine
(9) months following the termination of the Optionee’s Service, and (ii) the Final Exercise Date, and then, except to the extent previously exercised, will thereupon immediately terminate. 

4. Share Restrictions, Etc. Not later than upon the execution of this Agreement and as a condition to the effectiveness of this Stock
Option, the Optionee shall execute and deliver a counterpart signature page to, and become a party to, the Stockholders Agreement as a “Manager” thereunder. The Optionee’s rights hereunder (including with respect to shares received
upon exercise) are subject to the additional restrictions and other provisions contained in the Stockholders Agreement. 
 5. Legends,
Etc. Shares issued upon exercise of the Stock Option or otherwise delivered in satisfaction of the Stock Option will bear such legends as may be required or provided for under the terms of the Stockholders Agreement. 

6. Transfer of Stock Option. The Stock Option may not be transferred except as expressly permitted under Section 6(a)(3) of the
Plan. 

  
 -4- 

 7. Withholding. The Optionee expressly acknowledges and agrees that the Optionee’s
rights hereunder, including the right to be issued shares upon exercise, are subject to the Optionee’s promptly paying, or in respect of any later requirement of withholding being liable promptly to pay at such time as such withholdings are
due, to the Company in cash (or by such other means as may be acceptable to the Administrator in its discretion) all taxes required to be withheld, if any. No shares will be transferred pursuant to the exercise of the Stock Option unless and until
the person exercising the Stock Option has remitted to the Company an amount in cash sufficient to satisfy any federal, state, or local requirements with respect to tax withholdings then due and has committed (and by exercising the Stock Option the
Optionee shall be deemed to have committed) to pay in cash all tax withholdings required at any later time in respect of the transfer of such shares, or has made other arrangements satisfactory to the Administrator with respect to such taxes. The
Optionee also authorizes the Company and its subsidiaries to withhold such amounts from any amounts otherwise owed to the Optionee, but nothing in this sentence shall be construed as relieving the Optionee of any liability for satisfying its
obligations under the preceding provisions of this Section. 
 8. Effect on Service. Neither the grant of the Stock Option, nor the
issuance of shares upon exercise of the Stock Option, will give the Optionee any right to continued Service with the Company or any of its Affiliates, affect the right of the Company or any of its Affiliates to terminate the Management Agreement at
any time, or affect any right of such Optionee to terminate the Management Agreement at any time. 
 9. Governing Law. This Agreement
and all claims or disputes arising out of or based upon this Agreement or relating to the subject matter hereof will be governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any
choice or conflict of laws provision or rule that would cause the application of the domestic substantive laws of any other jurisdiction. 

By acceptance of the Stock Option, the Optionee agrees hereby to become a party to, and be bound by the terms of, the Stockholders Agreement
and to be subject to the terms of the Plan. For the avoidance of doubt, the provisions of this Agreement and the Plan shall apply to the Stock Option, including without limitation the vesting (if any) of the Stock Option, notwithstanding any
provision relating to the vesting or other treatment of equity-based awards of the Company or its Affiliates contained in any other agreement between the Optionee and the Company or any Affiliate. The Optionee further acknowledges and agrees that
(i) the signature to this Agreement on behalf of the Company is an electronic signature that will be treated as an original signature for all purposes hereunder and (ii) such electronic signature will be binding against the Company and
will create a legally binding agreement when this Agreement is countersigned by the Optionee. 
 [The remainder of this page intentionally
left blank] 

  
 -5- 

 Executed as of the 5th day of December, 2012. 

 

							
	Company:	 		 	INVENTIV GROUP HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Eric M. Sherbet

		 		 	Name:	 	Eric M. Sherbet
		 		 	Title:	 	General Counsel

  
 [Signature Page to
Non-Statutory MoM Performance-Based Option Agreement] 

							
	Optionee:	 		 	LIBERTY LANE IH LLC
				
		 		 	By:	 	 /s/ Paul M. Meister

		 		 	Name:	 	
		 		 	Title:	 	

  
 [Signature Page to
Non-Statutory MoM Performance-Based Option Agreement] 

 Schedule A 

Vesting Schedule 
 Unless
earlier terminated or forfeited, the Stock Option will vest, if at all, in accordance with the provisions of this Schedule A: 
 1.
The Stock Option will vest as to the excess, if any, of the specified percentage of Shares (determined on a straight-line basis between zero percent (0%) and one hundred percent (100%)) over the percentage of Shares previously vested, upon the
realization by the Investors of Cash Proceeds in respect of the Investor Shares of between 2 1⁄4x (with such specified percentage being zero percent (0%) of
the Shares subject to the Stock Option vesting at 2 1⁄4x or less) and
3 1⁄4x (with such specified percentage being one hundred percent (100%) of the Shares subject to the Stock Option vesting at 3 1⁄4x or more) of the Investment. No realization by the Investors of Cash Proceeds in respect of the Investor Shares that on a cumulative basis amount to 2 1⁄4x or less of the Investment shall result in any vesting of the Stock Option pursuant to this paragraph 1, but prior realizations shall be taken into account in
determining whether and if so to what extent any later realization by the Investors of Cash Proceeds in respect of the Investor Shares (occurring prior to the forfeiture or termination of the Stock Option) results in vesting pursuant to the
immediately preceding sentence. The vesting percentage shall be determined on each Determination Date. Notwithstanding the foregoing, except as provided in paragraph 2 of this Schedule A, the Stock Option shall not vest on any vesting date
unless the Optionee has remained in continuous Service from the Date of Grant until such vesting date. 
 2. On the Trigger Date (defined
herein), the unvested portion of the Stock Option will remain outstanding and eligible to vest in accordance with paragraph 1 above of this Schedule A until the earlier of (1) the fifth (5th) anniversary of the Trigger Date or
(2) the Final Exercise Date. The “Trigger Date” is the first date upon which all of the following have occurred: (i) each of Todd Abbrecht, Tony DiNovi and Scott Sperling ceases to be Managing Directors of Thomas H. Lee
Partners, L.P. (“THL”); and thereafter (ii) the Optionee’s Service ceases. 
 3. For purposes of this Agreement,
(A) the value of “Marketable Securities” shall be tested on (i) the date of initial receipt of Marketable Securities by the Investors (or, in the case of equity securities received by the Investors in respect of Investor Shares
that do not constitute Marketable Securities on the initial date of receipt, the date, if any, on which such equity securities received by the Investors first constitute Marketable Securities) (ii) in the case of Distributed Securities, the
date of the distribution by the Investor to its limited partners or members, as applicable, and (iii) in respect of all Marketable Securities other than Distributed Securities, the last day of each calendar quarter beginning with the calendar
quarter within which the initial receipt of such Marketable Securities to be tested occurred (or the date, if any, on which securities to be tested first constitute Marketable Securities, as applicable) so long as such Marketable Securities
constituted Marketable Securities on at least a majority of the days during such calendar quarter, and in the case of each of clauses (A)(i), (A)(ii) and (A)(iii) above only to the extent (x) such measurement date occurs while the Stock Option
remains 

 
outstanding and eligible to vest in accordance with paragraphs 1 and 2 of this Schedule A and (y) with respect to a measurement date on which the value of the Marketable Securities is
determined pursuant to clause (B)(iii) below, there exists a Trading Price in respect of such Marketable Securities for each of the thirty (30) consecutive Trading Days immediately preceding such measurement date (each of the foregoing testing
dates, a “measurement date”), and (B) the value of Marketable Securities for purposes of each measurement date hereunder shall be equal to (i) in the case of Marketable Securities received in a Change of Control and that
constitute Marketable Securities on the date of receipt, the value attributed to such securities in the Change of Control, (ii) in the case of Marketable Securities that constitute Marketable Securities as a result of their being Distributed
Securities, the value attributed to such securities by the Investors for purposes of making such distribution, and (iii) in all other circumstances the average of the Trading Price of such Marketable Securities over each of the thirty
(30) consecutive Trading Days immediately preceding (and including) the applicable measurement date; provided, however, that the Administrator, after consultation with the Chief Executive Officer, shall be entitled to make equitable adjustments
to the valuation methodology described in clause (B)(iii) above in respect of a particular measurement date in the event of an extraordinary transaction occurring during the thirty (30) Trading Day period ending on such measurement date.
Notwithstanding anything else in this paragraph 3, in no event shall the Stock Option remain outstanding beyond the Final Exercise Date. 

4. In the event (i) any equity securities received by the Investors in respect of the Investor Shares are excluded from the definition of
Marketable Securities when received (and at the time of a Change of Control if such equity securities are received prior to a Change of Control) as a result of the definition of Marketable Securities, (ii) a Change of Control occurs, and
(iii) the Stock Option does not fully vest in connection with the Change of Control immediately following which the Investors will continue to hold the equity securities that do not then constitute Marketable Securities, the Administrator will
provide, in connection with such Change of Control, for such adjustments with respect to the Stock Option as the Administrator, after consultation with the Company’s Chief Executive Officer, deems fair and equitable, which adjustments shall be
limited to providing for substitute equity awards, a “cash out” payment or a combination thereof, in each case subject to vesting conditions and other restrictions that are substantially the same as (or no less favorable to the Optionee
than) those contained in the Stock Option. 
 5. All determinations regarding the amount of Cash Proceeds received by the Investors in
respect of the Investor Shares and whether (or to what extent) this Stock Option has vested as a result thereof shall be made in good faith by the Board or by a committee designated by the Board, which determination shall be final and binding.EX-10.4

 Exhibit 10.4 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made effective as of September 15, 2010 (the “Effective Date”),
between inVentiv Health, Inc. (the “Company”) and Joseph Massaro (the “Executive”). 
 WHEREAS, the Company desires to
employ the Executive and the Executive desires to be employed on the terms and conditions set forth in this Agreement; 
 NOW, THEREFORE, in
consideration of the foregoing and of the respective covenants and agreements set forth herein, the Company and Executive agree as follows: 

1. Employment. The Company hereby offers to employ the Executive, and the Executive hereby accepts employment by the Company, in the
capacity and upon the terms and conditions hereinafter set forth. 
 2. Duties. The Executive shall serve as the Company’s Chief
Financial Officer and shall perform such duties, functions and responsibilities as are associated with and incident to that position and as the Company may, from time to time, require of him. The Executive shall serve the Company faithfully,
conscientiously and to the best of the Executive’s ability and shall promote the interests and reputation of the Company. Unless prevented by sickness or disability, the Executive shall devote all of the Executive’s time, attention,
knowledge, energy and skills, during normal working hours, and at such other times as the Executive’s duties may require, to the duties of the Executive’s employment. The principal place of employment of the Executive shall be at the
Company’s offices in Somerset, New Jersey and/or such other location as shall be necessary for the Executive to discharge the Executive’s duties hereunder. The Executive acknowledges that in the course of employment the Executive may be
required, from time to time, to travel on behalf of the Company. 
 3. Compensation and Benefits. As full and complete compensation
for the Executive’s execution and delivery of this Agreement and performance of any services hereunder, the Company shall pay, grant or provide the Executive, and the Executive agrees to accept, the following compensation and benefits: 

a. Base Salary. The Company shall pay the Executive a base salary at an annual rate of $360,000 payable in accordance with the
Company’s customary payroll practices as they may be adopted or modified from time to time. On an annual basis or at such other times as the board of directors of inVentiv Group Holdings, Inc. (the “Board”) may determine, the Board
may review the Executive’s performance and determine whether, in its sole discretion, the Company will increase (but not decrease) the Executive’s base salary. At no time during the pendency of this agreement shall the Company, without the
written consent of the Executive, decrease the Executive’s base salary. 
 b. Fringe Benefits. The Company shall afford the
Executive the opportunity to participate in any health care, dental, disability insurance, retirement, savings and any other employee benefits plans, policies or arrangements which the Company maintains for its employees generally in accordance with
the written terms of such plans, policies or arrangements. Nothing in this Agreement shall require the Company or its affiliates to establish, 

 
maintain or continue any benefit plans, policies or arrangements or restrict the right of the Company or any of its affiliates to amend, modify or terminate any such benefit plan, policy or
arrangement. 
 c. Bonus. The Executive shall be eligible for a bonus in each calendar year, based on the Executive’s success in
reaching or exceeding performance objectives as determined by the Company’s Chief Executive Officer or his/her designee, the amount of such bonus, if any, to be determined in the discretion of the Company, and subject to the Executive remaining
employed by the Company through the bonus payout date. Such bonus payout will be paid at the same time bonuses are paid to executive officers generally (the “Bonus Payment Date”). The bonus range shall be from zero percent (0%) to
one-hundred-and-fifty percent (150%) (seventy-five percent (75%) target), with the amount of such bonus, if any, that is awarded remaining subject to the discretion of the Company. 

d. Equity Incentive Grant Arrangements. All options or other equity-based awards granted to the Executive under the inVentiv Group
Holdings, Inc. 2010 Equity Incentive Plan (the “2010 Plan”) shall vest in accordance with the vesting provisions set forth in the 2010 Plan and the award agreement evidencing the Executive’s grant. 

e. Business Expenses. The Executive shall be entitled to reimbursement or payment of reasonable business expenses in accordance with
the Company’s policies, as the same may be amended from time to time in the Company’s sole discretion, following the Executive’s submission of appropriate receipts, bills and/or expense reports to the Company in accordance with such
policies. Any amount that the Executive is entitled to have reimbursed or to have paid on the Executive’s behalf under this Section 3(e) or elsewhere in this Agreement that would constitute nonqualified deferred compensation subject to
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and the regulations and guidance thereunder (“Section 409A”) shall be subject to the following additional rules: (i) no reimbursement of any
such expense shall affect the Executive’s right to reimbursement of any such expense in any other taxable year; (ii) reimbursement of the expense shall be made, if at all, promptly, but not later than the end of the calendar year following
the calendar year in which the expense was incurred; and (iii) the right to reimbursement shall not be subject to liquidation or exchange for any other benefit. 

f. Vacations, Holidays or Temporary Leave: The Executive shall be entitled to take five (5) weeks of vacation per year, without
loss or diminution of compensation, in accordance with the Company’s policies. Such vacation shall be taken at such time or times consistent with the needs of the Company’s business. The Executive shall further be entitled to the number of
paid holidays, and leaves for illness or temporary disability in accordance with the Company’s policies as such policies may be amended from time to time or terminated in the Company’s sole discretion. 

g. Car Allowance: During the period of the Executive’s employment by the Company, the Company shall pay to the Executive as a car
allowance the gross amount of $800 per month. Any car allowance payment under this Section 3(g) will be paid no later than sixty (60) days following the end of the month in which the expense was incurred. 

  
 -2- 

 h. Double-Trigger Change in Control Payment. If there is a Change in Control following the
Effective Date, and if within the two (2) months immediately preceding such Change in Control or within the twelve (12) months immediately following such Change in Control, the Executive’s employment hereunder is terminated by the
Company Without Cause (pursuant to Paragraph 5(a)(iv) below) or by the Executive for Good Reason (pursuant to Paragraph 5(a)(v) below), the Executive shall be entitled to a lump-sum payment equal to (a) fifty-two (52) weeks’ base
salary plus (b) the average annual bonus paid to the Executive under Section 3(c) hereof for the two (2) preceding fiscal years (or, if the Termination Date (as defined below) occurs before the second Bonus Payment Date hereunder, the
actual bonus paid to the Executive for the preceding fiscal year), with any pro-rated bonus awarded for a partial fiscal year annualized for purposes of such calculation, provided that if the Termination Date occurs before the first Bonus Payment
Date hereunder, the amount payable under this Section 3(h)(b) shall equal zero, minus such deductions as may be required by law or reasonably requested by the Executive (the “Double-Trigger Change in Control Payment”); provided,
however, that no payment shall be made hereunder if the Executive’s employment is terminated for any reason other than Without Cause or by the Executive for Good Reason or if, in the sole judgment and discretion of the Company, the Executive
fails to perform satisfactorily all assigned duties, including using his best efforts to facilitate such Change in Control. The Double-Trigger Change in Control Payment will be paid on the date that is sixty (60) days following the date the
Executive’s employment terminates. The Executive acknowledges that the payments provided for in this Section 3(h) are in lieu of (and not in addition to) any other payments or benefits to which the Executive might otherwise be entitled in
connection with a Change in Control, including, but not limited to, any stay bonuses, severance payments or termination benefits of any kind offered to employees in connection with a Change in Control, whether pursuant to a plan, arrangement, policy
or otherwise; provided, however, that nothing herein shall effect the Executive’s right to payment pursuant to paragraph 6(c) of this agreement. The Executive’s receipt of the Double-Trigger Change in Control Payment will be subject to
Executive signing and not revoking a separation agreement and release of claims in a form reasonably acceptable to the Company (together, the “Release”) that is effective within sixty (60) days following the Termination Date (as
defined below) or such earlier time required by the Release (such deadline, the “Release Deadline”). If the Release does not become effective by the Release Deadline, Executive will forfeit any right to the Double-Trigger Change in Control
Payment. The Company shall use good faith efforts to obtain the Executive’s signature on the Release and to cause it to become effective by the Release Deadline. In no event will the Double-Trigger Change in Control Payment be paid until the
Release becomes effective. 
 4. Non-Competition, Confidentiality, Discoveries and Works: 

a. Non-Competition: During the period of the Executive’s employment at the Company and for twelve (12) months following the
termination of the Executive’s employment for any reason, the Executive agrees not to compete in any manner, either directly or indirectly, whether for compensation or otherwise, with the Company or any affiliate, or to assist any other person
or entity to compete with the Company or any affiliate either: 
 (i) by producing, developing or marketing, or assisting others to produce,
develop or market, or 

  
 -3- 

 (ii) by accepting employment from or having any other relationship (including, without
limitation, through owning, managing, operating, controlling or consulting) with any entity which produces, develops or markets, 
 a product, process, or
service which is competitive with those products, processes, or services of the Company or any affiliate, whether existing or planned for in the future, on which the Executive has worked, or concerning which the Executive has in any manner acquired
knowledge of or had access to Confidential Information (as defined in Section 4(e)(iii) below), provided, however, that it shall not be a violation of this Agreement for the Executive to seek and/or accept employment directly with
a fully integrated pharmaceutical or biotech company (i.e. one that discovers, develops, manufactures, and promotes drugs) or to have beneficial ownership of less than one percent (1%) of the outstanding amount of any class of securities listed
on a national securities exchange or quoted on an inter-dealer quotation system. 
 b. Non-Solicitation: During the period of the
Executive’s employment at the Company and for twelve (12) months following the termination of the Executive’s employment for any reason, the Executive agrees that the Executive will not, either on the Executive’s own behalf or on
behalf of any other person or entity (other than for the benefit of the Company or any affiliate), directly or indirectly, (i) solicit any person or entity that is a customer of the Company or any affiliate, or has been a customer of the
Company or any affiliate during the prior twelve (12) months, to purchase any products or services the Company or any affiliate provides or could provide to the customer, or (ii) interfere with any of Company’s or any affiliate’s
business relationships. 
 c. No-Hire: During the period of the Executive’s employment at the Company and for twelve
(12) months following the termination of the Executive’s employment for any reason, the Executive agrees that the Executive will not, either on the Executive’s own behalf or on behalf of any other person or entity, directly or
indirectly, hire, solicit or encourage to leave the employ of or engagement by the Company any person who is then an employee or contractor of the Company or any affiliate or who was an employee or contractor of the Company or any affiliate within
twelve (12) months of the date of such hiring, soliciting, or encouragement to leave the Company or any affiliate. 
 d. Geographic
Scope: The foregoing restrictions shall apply in the “Restricted Area” which means any geographic area where the Company or any of its affiliates conduct business, or are actively planning to conduct business, as of the date the
Executive’s employment terminates. 
 e. Confidentiality: 

(i) During the period of the Executive’s employment at the Company and for all time following the termination of the Executive’s
employment for any reason, the Executive shall hold all Confidential Information of the Company in a fiduciary capacity and agrees not to take any action which would constitute or facilitate the Unauthorized use or disclosure of Confidential
Information. The Executive further agrees to take all reasonable measures to prevent the Unauthorized use and disclosure of Confidential Information and to prevent Unauthorized persons or entities from obtaining or using Confidential Information.
The terms “Confidential Information” and “Unauthorized” shall have the meanings set forth Sections 4(e)(iii) and (iv) of this Agreement respectively. 

  
 -4- 

 (ii) Promptly upon termination of the Executive’s employment with the Company for any
reason, the Executive agrees to deliver to the Company all property and materials within the Executive’s possession or control which belong to the Company or which contain Confidential Information. 

(iii) As used in this Agreement, the term “Confidential Information” shall mean trade secrets, confidential or proprietary
information, and all other information, documents or materials, owned, developed or possessed by the Company, its parents, subsidiaries or affiliates, their respective predecessors and successors, whether in tangible or intangible form, that is not
generally known to the public. Confidential Information includes, but is not limited to, (a) financial information, (b) products, (c) product and service costs, prices, profits and sales, (d) new business ideas, (e) business
strategies, (f) product and service plans, (g) marketing plans and studies, (h) forecasts, (i) budgets, (j) projections, (k) computer programs, (l) data bases and the documentation (and information contained
therein), (m) computer access codes and similar information, (n) software ideas, (o) know-how, technologies, concepts and designs, (p) research projects and all information connected with research and development efforts,
(q) records, (r) business relationships, methods and recommendations, (s) existing or prospective client, customer, vendor and supplier information (including, but not limited to, identities, needs, transaction histories, volumes,
characteristics, agreements, prices, identities of individual contacts, and spending, preferences or habits), (t) training manuals and similar materials used by the Company in conducting its business operations, (u) skills,
responsibilities, compensation and personnel files of Company employees, directors and independent contractors, (v) competitive analyses, (w) contracts with other parties, and (x) other confidential or proprietary information that has
not been made available to the general public by the Company’s senior management. 
 (iv) As used in this Agreement, the term
“Unauthorized” shall mean: (a) in contravention of the Company’s policies or procedures; (b) otherwise inconsistent with the Company’s measures to protect its interests in the Confidential Information; (c) in
contravention of any lawful instruction or directive, either written or oral, of a Company employee empowered to issue such instruction or directive; (d) in contravention of any duty existing under law or contract; or (e) to the detriment
of the Company. 
 (v) In the event that the Executive is requested by any governmental or judicial authority to disclose any Confidential
Information, the Executive shall give the Company prompt notice of such request (including, by giving the Company a copy of such request if it is in writing), such that the Company may seek a protective order or other appropriate relief, and in any
such proceeding the Executive shall disclose only so much of the Confidential Information as is required to be disclosed. 
 f.
Discoveries and Works: All discoveries and works made or conceived by the Executive during and in the course of his employment by the Company, jointly or with others, that relate to the Company’s activities shall be owned by the Company.
The terms “discoveries and works” include, by way of example, inventions, computer programs (including documentation of such programs), technical improvements, processes, drawings, and works of

  
 -5- 

 
authorship, including all educational and sales materials or other publications which relate to Company’s current business. The Executive hereby assigns and agrees to assign to the Company
(or as otherwise directed by the Company) the Executive’s full right, title and interest in and to all discoveries and works. The Executive shall promptly notify and make full disclosure to, and execute and deliver any documents requested by,
the Company to evidence or better assure title to such discoveries and works by the Company, assist the Company in obtaining or maintaining for itself at its own expense United States and foreign patents, copyrights, trade secret protection and
other protection of any and all such discoveries and works, and promptly execute, whether during his employment or thereafter, all applications or other endorsement’s necessary or appropriate to maintain patents and other rights for the Company
and to protect its tide thereto. Any discoveries and works which, within six (6) months after the termination of the Executive’s employment hereunder, are made, disclosed, reduce to a tangible or written form or description, or are reduced
to practice by the Executive and which pertain to work performed by the Executive while with, and in his capacity as an Executive of, the Company shall, as between the Executive and the Company presumed to have been made during the Executive’s
employment by the Company. 
 g. Representations, Warranties and Acknowledgements 

(i) The Executive acknowledges that (a) the Company considers Confidential Information to be commercially and competitively valuable to
the Company and critical to its success; (b) Unauthorized use or disclosure of Confidential Information would cause irreparable harm to the Company; and (c) by this Agreement, the Company is taking reasonable steps to protect its
legitimate interests in its Confidential Information. 
 (ii) The Executive also acknowledges that businesses that are competitive with the
Company include, but are not limited to, any business involving marketing, consulting to or contract sales, detailing and marketing support or any other marketing services for pharmaceutical or any other related health care or biotechnology
companies, including competitive e-health businesses. 
 (iii) The Executive represents and warrants to the Company that he is not a party
to any agreement, or non-competition or other covenant or restriction contained in any agreement, commitment, arrangement or understanding (whether oral or written), that in any way conflicts with or limits the Executive’s ability to commence
or continue to render services to the Company or that would otherwise limit the Executive’s ability to perform all responsibilities in accordance with the terms and subject to the conditions of the Executive’s employment. 

(iv) The Executive consents and agrees that, during the Executive’s employment with Company and thereafter, the Company may review,
audit, intercept, access and disclose all communications created, received or sent over the electronic mail and internet access system provided by Company with or without notice to the Executive and that such review, audit, interception, access, or
disclosure may occur during or after working hours. The Executive further consents and agrees that the Company may, at any time, access and review the contents of all computers, computer disks, other data storage equipment, and devices, files,
desks, drawers, closets, cabinets and work stations which are either on, Company’s premises or which are owned or provided by Company. 

  
 -6- 

 h. Remedies: In the event of breach or threatened breach by the Executive of any provision
of Section 4 hereof, the Company shall, be entitled to obtain (i) temporary, preliminary and permanent injunctive relief, in each case without the posting of any bond or other security, (ii) damages and an equitable accounting of all
earnings, profits and other benefits arising from such breach, or threatened breach, (iii) recovery of all attorney’s fees and costs incurred by the Company in obtaining such relief, (iv) repayment of any severance, change in control
payments, or benefits paid to the Executive pursuant to this Agreement or any compensation or benefit plan or arrangement of the Company, and (v) any other legal and equitable relief to which it may be entitled, including any and all monetary
damages which Company may incur as a result of said breach or threatened breach. Pending arbitration pursuant to Section 7 of the Agreement, the Company shall be entitled to cease making any payments or providing any benefits to the Executive
and to obtain temporary and preliminary injunctive relief as described in Section 4(h)(i) from a court of competent jurisdiction. The Company may pursue any remedy available, including declaratory relief, concurrently or consecutively, in any
order, and the pursuit of one such remedy at any time will not be deemed an election of remedies or waiver of the right to pursue any other remedy. 

i. Early Resolution Conference: This Agreement is understood to be clear and enforceable as written and is executed by both parties on
that basis. However, should the Executive later challenge any provision as unclear, unenforceable, or inapplicable to any activity that the Executive intends to engage in, the Executive will first notify Company in writing and meet with a
Company representative and a neutral mediator (if the Company elects to retain one at its expense) to discuss resolution of any disputes between the parties. The Executive will provide this notification at least fourteen (14) days before the
Executive engages in any activity on behalf of a competing business or engages in other activity that could foreseeably fall within a questioned restriction. The failure to comply with this requirement shall waive the Executive’s right to
challenge the reasonable scope, clarity, applicability, or enforceability of the Agreement and its restrictions at a later time. All rights of both parties will be preserved if the Early Resolution Conference requirement, as set out in this
Section 4(i), is complied with even if no agreement is reached in the conference. 
 5. Termination of Employment: 

a. The Executive is an employee at-will, and either the Executive or the Company may terminate the employment relationship at any time for any
reason with or without Cause (as defined below). The date upon which the termination of the Executive’s employment becomes effective pursuant to this Agreement shall be referred to herein as the “Termination Date.” The Termination
Date shall be the date upon which any of the following events shall occur: 
 (i) the death of the Executive; 

(ii) the Disability (as defined below) of the Executive; 

(iii) the Company’s delivery of a written notice to the Executive of a termination of the Executive’s employment for Cause (as
defined below); 

  
 -7- 

 (iv) the Company’s delivery of a written notice to the Executive of a Executive’s
employment Without Cause (as defined below); or 
 (v) the Executive’s delivery of a written notice to the Company of a
Executive’s employment for Good Reason (as delivered below); or 
 (vi) resignation by the Executive. 

For purposes of this Agreement, the Executive’s employment will not be deemed to have automatically terminated upon a Change in Control (as defined
below). 
 b. For purposes of this Agreement, the “Disability” of the Executive shall mean the Executive’s inability, because
of mental or physical illness or incapacity, whether total or partial, to perform substantially all of the duties and responsibilities of the Executive’s employment with or without reasonable accommodation, and which continues for a length of
time that exceeds any period of leave to which the Executive is entitled and following which the Executive has a right to be restored to the same job or to an equivalent job under federal, state or local law. 

c. For purposes of this Agreement, the term “Cause” shall mean the Executive’s (i) conviction of, or entry of a plea of
guilty or nolo contendere with respect to, any felony; (ii) commission of any act of willful misconduct, gross negligence, fraud or dishonesty; (iii) violation of any term of this Agreement or any written policy of the Company; or
(iv) inability to meet the performance objectives for his position. 
 d. For purposes of this Agreement, “Without Cause”
shall mean for any reason(s) whatsoever (other than the reasons described in Sections 5(a)(i), 5(a)(ii), 5(a)(iii) and 5(a)(iv) hereof). 

e. For purposes of this Agreement, “Good Reason” shall mean (i) a material diminution in the Executive’s duties;
(ii) a material reduction in the Executive’s total compensation; (iii) the relocation of Executive’s primary location for providing services to the Company more than one hundred (100) miles from Executive’s then current
primary location of providing services to the Company; or (iv) a material breach of the Agreement by the Company. Provided, however, that Executive will not resign for Good Reason without first providing written notice to the Company within
ninety (90) days of the event Executive believes constitutes Good Reason, specifically identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30) days following the
date of such notice, and terminating his employment for Good Reason within thirty (30) days following the expiration of the cure period if the Company fails to remedy the condition. 

f. For purposes of this Agreement, a “Change in Control” means any change in the ownership of the capital stock of inVentiv Group
Holdings, Inc. (“Holdings”) if, immediately after giving effect thereto, (i) any parson (or group of persons acting in concert) other than Thomas H. Lee Partners, L.P. and its related investment funds (the “Investors”) that
hold shares of the Company’s common stock (“Stock”) will have the direct or indirect power to elect a majority of the members of the Board or (ii) the Investors shall own less than 25% of the Equivalent Shares. 

  
 -8- 

 g. For purposes of this Agreement, “Equivalent Shares” means, at any date of
determination, (i) as to any outstanding shares of Stock, such number of shares of Stock and (ii) as to any outstanding options, warrants or convertible securities, the maximum number of shares of Stock for which or into which such
options, warrants or convertible securities may at the time be exercised, converted or exchanged (or which will become exercisable, convertible or exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which
the number of Equivalent Shares is to be determined). 
 6. Payments Upon Termination of Employment. 

a. Death or Disability. If the Executive’s employment hereunder is terminated due to the Executive’s death or Disability
pursuant to Sections 5(a)(i) or (ii) hereof, the Company shall pay or provide to the Executive, the Executive’s designated beneficiary or to the Executive’s estate (i) all base salary pursuant to Section 3(a) hereof which
has been earned but unpaid as of the Termination Date and any vacation time pursuant to Section 3(f) hereof which has been earned but unused as of the Termination Date, each of which shall be paid within thirty (30) days following the
Termination Date; and (ii) any benefits to which the Executive may be entitled under any employee benefits plan, policy or arrangement pursuant to Section 3(b) hereof (including, but not limited to, life insurance and disability insurance)
in which he is a participant in accordance with the written terms of such plan, policy or arrangement up to and including the Termination Date. 

b. Termination for Cause or Resignation. If the Executive’s employment hereunder is terminated by the Company for Cause pursuant
to Section 5(a)(iii) or due to the Executive’s resignation pursuant to Section 5(a)(vi), the Company shall pay or provide to the Executive (i) all base salary pursuant to Section 3(a) hereof which has been earned but unpaid
as of the Termination Date and any vacation time pursuant to Section 3(f) hereof which has been earned but unused as of the Termination Date, each of which shall be paid within thirty (30) days following the Termination Date; and
(ii) any benefits to which the Executive may be entitled under any employee benefits plan, policy or arrangement pursuant to Section 3(b) hereof in which he is a participant in accordance with the written terms of such plan, policy or
arrangement up to and including the Termination Date. 
 c. Termination Without Cause or for Good Reason. If the Executive’s
employment hereunder is terminated by the Company Without Cause pursuant to Section 5(a)(iv) or by the Executive for Good Reason pursuant to Section 5(a)(v), subject to the terms and conditions of this Agreement, including Sections 6(d)
and 6(e) below, the Company shall (i) pay the Executive a lump-sum severance payment equal to fifty-two (52) weeks’ base salary, minus such deductions as may be required by law or reasonably requested by the Executive, on the date
which is sixty (60) days following the Termination Date and (ii) for a period of fifty-two (52) weeks following the Termination Date, provide for medical and dental continuation coverage for the Executive, his spouse, and eligible
dependents, on the terms set forth below ((i) and (ii) together are hereinafter ‘‘Severance”). If the Executive is enrolled in the Company’s medical and dental plans on the Termination Date, he may elect to continue his
participation and that of his spouse and eligible dependents in those plans for a period of time under the federal law commonly known as “COBRA”. If the Executive elects coverage under COBRA by signing and returning the COBRA election form
provided by the Company no later than the date he is 

  
 -9- 

 
required to sign and return the Release, then, for a period of fifty-two (52) weeks following the Termination Date, provided he remains eligible for coverage under COBRA and the
Company’s medical and dental plans, the Executive will pay the full monthly premium cost under Section 4980 of the Code, and the Company shall pay the Executive a cash amount equal, on an after-tax basis, to the Company’s portion of
the premium cost of the Executive’s coverage and that of his spouse and eligible dependents under those plans as of the Termination Date. The Company shall make such payments to the Executive on the first business day of each month, commencing
with the month immediately following the Termination Date, provided that the first two payments shall be made on the sixtieth (60) calendar day after the Termination Date. The Company shall have no further obligation to make such payments to
the Executive after the earlier of (x) the month following the date that the Executive (or, where applicable, his spouse and eligible dependents) cease to participate in the Company medical and dental plans or otherwise elect not to continue
the applicable medical or dental coverages described in this Section 6(c) and (y) the date that is fifty-two (52) weeks following the Termination Date. The Executive shall keep the Company informed on whether or not the Executive has
obtained new employment and upon request shall provide documentation to the Company regarding the Executive’s employment status during the period in which the Executive receives Severance from the Company. In addition, the Company shall pay or
provide to the Executive (A) all base salary pursuant to Section 3(a) hereof which has been earned but unpaid as of the Termination Date and any vacation time pursuant to Section 3(f) hereof which has been earned but unused as of the
Termination Date, each of which shall be paid within thirty (30) days following the date of termination of employment; and (B) any benefits to which the Executive may be entitled under any employee benefits plan, policy or arrangement
pursuant to Section 3(b) hereof in which he is a participant in accordance with the written terms of such plan, policy or arrangement up to and including the Termination Date. 

d. Release and Timing of Payments. The Executive’s receipt and the Company’s payment of any Severance pursuant to this
Section 6 will be subject to Executive signing and not revoking a separation agreement and release of claims in a form reasonably acceptable to the Company (together, the “Release”) that is effective within sixty (60) days
following the Termination Date or such earlier time required by the Release (such deadline, the “Release Deadline”). If the Release does not become effective by the Release Deadline, Executive will forfeit any rights to Severance under
this Agreement. The Company shall use good faith efforts to obtain the Executive’s signature on the Release and to cause it to become effective by the Release Deadline. In no event will Severance be paid until the Release becomes effective. In
the event Executive’s termination of employment occurs at a time during the calendar year where the Release could become effective in the calendar year following the calendar year in which Executive’s termination of employment occurs, then
any Severance payments under this Agreement that would be considered Deferred Payments (as defined in Section 6(e) below) will be paid on the first payroll date to occur during the calendar year following the calendar year in which such
termination of employment occurs, or, if later, the latest of (i) the Release Deadline, (ii) such time as required by the payment schedule applicable to each payment, or (iii) the time required by Section 6(e). 

  
 -10- 

 e. Section 409A. 

(i) Notwithstanding anything to the contrary in this Agreement, no severance that would otherwise be payable to or on behalf of Executive, if
any, pursuant to this Agreement, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (the “Deferred Payments”) will be payable until Executive
has a “separation from service” within the meaning of Section 409A. Similarly, no severance that would otherwise be payable to or on behalf of Executive, if any, pursuant to this Agreement that otherwise would be exempt from
Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has a “separation from service” within the meaning of Section 409A. 

(ii) Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of
Section 409A at the time of Executive’s termination of employment, then, if required, the Deferred Payments, which are otherwise due to Executive on or within the six (6) month period following Executive’s Termination Date will
accrue, to the extent required, during such six (6) month period and will become payable in a lump-sum payment on the date six (6) months and one (1) day following the date of Executive’s termination of employment or the date of
Executive’s death, if earlier. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to
constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. 
 (iii) Any severance payment that
satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-l(b)(4) of the Treasury Regulations shall not constitute Deferred Payments for purposes of this Agreement. Any amount paid under this Agreement
that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) will not constitute
Deferred Payments for purposes of this Agreement. For purposes of this Agreement, “Section 409A Limit” means the lesser of two (2) times: (i) Executive’s annualized compensation based upon the annual rate of pay paid to
Executive during the Company’s taxable year preceding the Company’s taxable year of Executive’s termination of employment as determined under Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance
issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s employment is terminated. 

(iv) The foregoing provision is intended to comply with the requirements of Section 409A so that none of the severance payments and
benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Executive and the Company agree to work together in good faith to consider
amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to the Executive under Section 409A, provided
that (i) the Company will not be required to take any such steps that impose any material additional costs on the Company and shall not take any such steps that impose any material additional costs on the Executive (unless the Executive
otherwise consents thereto) and (ii) the Company will not be liable for the imposition of any tax or penalty pursuant to Section 409A. 

  
 -11- 

 f. No Other Payments. Except as provided in this Section 6, the Executive shall not
be entitled to receive any other payments or benefits from the Company due to the termination of the Executive’s employment, including but not limited to, any employee benefits under any of the Company’s employee benefits plans or
arrangements (other than at the Executive’s expense under the Consolidated Omnibus Budget Reconciliation Act of 1985 or pursuant to the written terms of any pension benefit plan in which the Executive is a participant in which the Company may
have in effect from time to time) or any severance benefits. 
 g. Golden Parachute Tax Provisions. 

(i) The Company and the Executive shall use customary, reasonable and good faith efforts to avoid all, or any portion, of the payments
provided under this Agreement, either alone or together with other payments or benefits which the Executive receives or is entitled to receive from the Company or an affiliate, constituting an “excess parachute payment” within the meaning
of Section 280G of the Code, including by seeking an effective shareholder vote. 
 (ii) If, notwithstanding paragraph 6(g), all, or
any portion, of the payments provided under this Agreement, either alone or together with other payments or benefits which the Executive receives or is entitled to receive from the Company or an affiliate, would constitute an “excess parachute
payment” within the meaning of Section 280G of the Code, then, except to the extent the Executive shall have waived all or any portion of the following in connection with a shareholder vote described in Section 280G of the Code, the
Executive shall be entitled to receive (A) an amount limited so that no portion thereof shall fail to be tax deductible under Section 280G of the Code (the “Limited Amount”), or (B) if the amount otherwise payable hereunder
(without regard to clause (A)) reduced by all taxes applicable thereto (as reasonably determined by the Company but including, for the avoidance of doubt, the excise tax imposed by Section 4999 of the Code) would be greater than the Limited
Amount reduced by all taxes applicable thereto (as reasonably determined by the Company), the amount otherwise payable hereunder. 
 7.
Arbitration. 
 a. Any controversy or claim arising out of or relating to this Agreement, the employment relationship between the
Executive and the Company, or the termination thereof, including the arbitrability of any such controversy or claim, which cannot be resolved amicably after a reasonable attempt to negotiate such a resolution (including by exhaustion of all
grievance or claims procedures made available by the Company or any employee benefit plan of the Company) shall be submitted to arbitration under the auspices of the American Arbitration Association in accordance with its Commercial Dispute
Resolution Procedures and Rules, as such rules may be amended from time to time, and at its office nearest to the Company’s place of business where the Executive works or to which the Executive reports. The award of the arbitrator shall be
final and binding upon the parties, and judgment may be entered with respect to such award in any court of competent jurisdiction. Any arbitration under this Agreement shall be governed by and subject to the confidentiality restrictions set forth in
Section 4(e) of this Agreement. The Executive acknowledges reading, prior to the signing of this agreement, the Commercial Dispute Resolution Procedures and Rules of the American Arbitration Association, which are available via the internet at
http://www.adr.org. Notwithstanding the foregoing, any 

  
 -12- 

 
controversy or claim arising out of or relating to any claim by the Company for temporary or preliminary relief with respect to Section 4 of this Agreement need not be resolved in
arbitration and may be resolved in accordance with Section 4(h) of this Agreement. 
 b. The Executive acknowledges that this agreement
to submit to arbitration includes all controversies or claims of any kind (e.g., whether in contract or in tort, statutory or common law, legal or equitable) now existing or hereafter arising under any federal, state, local or foreign law (except
claims by the Company for temporary or preliminary injunctive relief pursuant to Section 4 as set forth above), including, but not limited to, the Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, the Civil Rights
Act of 1866, the Family and Medical Leave Act, the Employee Retirement Income Security Act, and the Americans With Disabilities Act, and all similar state laws, and the Executive hereby waives all rights thereunder to have a judicial tribunal
resolve such claims. 
 8. Deductions and Withholding. The Executive agrees that the Company shall withhold from any and all
compensation payable under this Agreement all federal, state, local and/or other taxes which the Company determines are required to be withheld under applicable statutes and/or regulations from time to time in effect and all amounts required to be
deducted in respect of the Executive’s coverage by and participation in applicable employee benefit plans, policies or arrangements. 

9. Entire Agreement. This Agreement embodies the entire agreement of the parties with respect to the Executive’s employment and
supersedes any other prior oral or written agreements between the Executive and the Company and its affiliates. This Agreement may not be changed or terminated orally but only by an agreement in writing signed by the parties hereto. 

10. Waiver. The waiver by the Company of a breach of any provision of this Agreement by the Executive shall not operate or be construed
as a waiver of any subsequent breach by the Executive. The waiver by the Executive of a breach of any provision of this Agreement by the Company shall not operate or be construed as a waiver of any subsequent breach by the Company. 

11. Governing Law. Because the Company is incorporated in the state of Delaware, this Agreement shall be governed by, and construed in
accordance with, the laws of the State of Delaware, without regard to the choice of law rules of any state or where the Executive is in fact required to work. 

12. Jurisdiction. Any legal suit, action or proceeding against any party hereto arising out of or relating to this Agreement that is
not subject to arbitration pursuant to Section 7 of this Agreement shall be instituted in a New Jersey federal or state court in the County of Somerset and each party hereto waives any objection which it may now or hereafter have to the laying
of venue of any such suit, action or proceeding and each party hereto irrevocably submits to the jurisdiction of any such court in any suit, action or proceeding. 

13. Assignability. The obligations of the Executive may not be delegated and, except as expressly provided in Section 6(a)
relating to the designation of beneficiaries, the Executive may not, without the Company’s written consent thereto, assign, transfer, convey, pledge, 

  
 -13- 

 
encumber, hypothecate or otherwise dispose of this Agreement or any interest therein. Any such attempted delegation or disposition shall be null and void and without effect. The Company and the
Executive agree that this Agreement and all of the Company’s rights and obligations hereunder may be assigned or transferred by the Company to and may be assumed by and become binding upon and may inure to the benefit of any affiliate of or
successor to the Company. The term “successor” shall mean (with respect to the Company or any of its subsidiaries) any other corporation or other business entity, which, by merger, consolidation, purchase of the assets, or otherwise,
acquires all or a material part of the assets of the Company. Any assignment by the Company of its rights or obligations hereunder to any affiliate of or successor to the Company shall not be a termination of employment for purposes of this
Agreement. 
 14. Severability. If any provision of this Agreement as applied to either party or to any circumstances shall be
adjudged by a court of competent jurisdiction or arbitrator to be void or unenforceable, the same shall in no way affect any other provision of this Agreement or the validity or enforceability of this Agreement. If any court or arbitrator construes
any of the provisions of Section 4 hereof, or any part thereof, to be unreasonable because of the duration of such provision or the geographic or other scope thereof, such court or arbitrator may reduce the duration or restrict the geographic
or other scope of such provision and enforce such provision as so reduced or restricted. 
 15. Notices. All notices to the Executive
hereunder shall be in writing and shall be delivered personally, sent by overnight courier or sent by registered or certified mail, return receipt requested, to: 

Joseph Massaro 
 36 Village Road

 Unit 601 
 Middleton, MA
01949 
 All notices to the Company hereunder shall be in writing and shall be delivered personally, sent by overnight courier or sent by
registered or certified mail, return receipt requested, to: 
 inVentiv Health, Inc. 

200 Cottontail Lane 
 Somerset,
NJ 08873 
 Attention: Executive Director, Human Resources 

Either party may change the address to which notices shall be sent by sending written notice of such change of address to the other party. 

16. Section Headings. The section headings contained in this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement. 

  
 -14- 

 17. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which taken together shall constitute one and the same instrument. 
 18. Voluntary
Agreement. The Executive acknowledges that before entering into this Agreement, the Executive has had the opportunity to consult with any attorney or other advisor of his choice, and that this Section 18 of this Agreement constitutes advice
from the Company to do so if he chooses. The Executive further acknowledges that he has entered into this Agreement of his own free will, and that no promises or representations have been made to him by any person to induce him to enter into this
Agreement other than the express terms set forth herein. The Executive further acknowledges that he has read this Agreement and understands all of its terms, including the waiver of the right to have all disputes with and claims against the Company
decided in a judicial forum set forth in Section 7. 
 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of
the date first above written. 
  

			
	INVENTIV HEALTH, INC.
		
	By:	 	 /s/ R. Blane Walter

		 	R. Blane Walter
		 	Chief Executive Officer
	
	EXECUTIVE
	
	 /s/ Joseph Massaro

	Joseph Massaro

  
 -15-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]